These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24612112)

  • 1. A critical role for the melanocortin 4 receptor in stress-induced relapse to nicotine seeking in rats.
    Qi X; Yamada H; Corrie LW; Ji Y; Bauzo RM; Alexander JC; Bruijnzeel AW
    Addict Biol; 2015 Mar; 20(2):324-35. PubMed ID: 24612112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse.
    Bruijnzeel AW; Prado M; Isaac S
    Biol Psychiatry; 2009 Jul; 66(2):110-7. PubMed ID: 19217073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.
    Yuan M; Malagon AM; Yasuda D; Belluzzi JD; Leslie FM; Zaveri NT
    Behav Brain Res; 2017 Aug; 333():251-257. PubMed ID: 28693859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of α2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats.
    Yamada H; Bruijnzeel AW
    Neuropharmacology; 2011; 60(2-3):303-11. PubMed ID: 20854830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide systems and new treatments for nicotine addiction.
    Bruijnzeel AW
    Psychopharmacology (Berl); 2017 May; 234(9-10):1419-1437. PubMed ID: 28028605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a D3 receptor antagonist on context-induced reinstatement of nicotine seeking.
    Sabioni P; Di Ciano P; Le Foll B
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():149-54. PubMed ID: 26279138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic treatment with the vasopressin 1b receptor antagonist SSR149415 prevents the dysphoria associated with nicotine withdrawal in rats.
    Qi X; Guzhva L; Ji Y; Bruijnzeel AW
    Behav Brain Res; 2015 Oct; 292():259-65. PubMed ID: 26112757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats.
    Igari M; Alexander JC; Ji Y; Qi X; Papke RL; Bruijnzeel AW
    Neuropsychopharmacology; 2014 Jan; 39(2):455-65. PubMed ID: 23966067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the CRF receptor antagonist D-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats.
    Zislis G; Desai TV; Prado M; Shah HP; Bruijnzeel AW
    Neuropharmacology; 2007 Dec; 53(8):958-66. PubMed ID: 17976662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats.
    Bruijnzeel AW; Ford J; Rogers JA; Scheick S; Ji Y; Bishnoi M; Alexander JC
    Pharmacol Biochem Behav; 2012 Mar; 101(1):62-8. PubMed ID: 22182462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained AAV-mediated overexpression of CRF in the central amygdala diminishes the depressive-like state associated with nicotine withdrawal.
    Qi X; Shan Z; Ji Y; Guerra V; Alexander JC; Ormerod BK; Bruijnzeel AW
    Transl Psychiatry; 2014 Apr; 4(4):e385. PubMed ID: 24755994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats.
    Qi X; Guzhva L; Yang Z; Febo M; Shan Z; Wang KKW; Bruijnzeel AW
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1378-1389. PubMed ID: 27461514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats.
    Dravolina OA; Zakharova ES; Shekunova EV; Zvartau EE; Danysz W; Bespalov AY
    Neuropharmacology; 2007 Feb; 52(2):263-9. PubMed ID: 16963088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats.
    Bruijnzeel AW; Zislis G; Wilson C; Gold MS
    Neuropsychopharmacology; 2007 Apr; 32(4):955-63. PubMed ID: 16943772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats.
    Marcinkiewcz CA; Prado MM; Isaac SK; Marshall A; Rylkova D; Bruijnzeel AW
    Neuropsychopharmacology; 2009 Jun; 34(7):1743-52. PubMed ID: 19145226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in mechanisms underlying reinstatement of cigarette smoke extract- and nicotine-seeking behavior in rats.
    Cross SJ; Reynaga DD; Cano M; Belluzzi JD; Zaveri NT; Leslie FM
    Neuropharmacology; 2020 Jan; 162():107846. PubMed ID: 31704271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.
    Bruijnzeel AW; Bishnoi M; van Tuijl IA; Keijzers KF; Yavarovich KR; Pasek TM; Ford J; Alexander JC; Yamada H
    Psychopharmacology (Berl); 2010 Dec; 212(4):485-99. PubMed ID: 20697697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
    Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
    J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats.
    Grella SL; Funk D; Coen K; Li Z; Lê AD
    Behav Brain Res; 2014 May; 265():188-97. PubMed ID: 24583188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of the nicotinic acetylcholine receptor agonists ABT-089 and ABT-107 attenuates the reinstatement of nicotine-seeking behavior in rats.
    Lee AM; Arreola AC; Kimmey BA; Schmidt HD
    Behav Brain Res; 2014 Nov; 274():168-75. PubMed ID: 25128791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.